+关注
琦航爸爸
暂无个人介绍
IP属地:广东
27
关注
0
粉丝
3
主题
0
勋章
主贴
热门
琦航爸爸
2022-11-09
$艾美疫苗(06660)$
流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿
@小虎产品经理
琦航爸爸
2019-12-17
最近几个新股能打吗赤子城惠州银行台山水务
琦航爸爸
2020-10-29
$蚂蚁集团(06688)$
我估计蚂蚁第一天就是10左右涨幅
琦航爸爸
2020-01-17
驴迹科技怎么看??中签了,昨天暗盘大跌
琦航爸爸
2022-10-07
5.4是什么水平?
【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩
琦航爸爸
2022-03-15
外资投行就是做空。。都跌到市净率一半了。。还在发做空报告
小摩:维持新华保险“减持”评级 目标价降11.8%至15港元
琦航爸爸
2020-02-11
亲们,这个是什么意思??
驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效
琦航爸爸
2020-01-16
$旷世控股(01925)$
这个股票太坑了。涨的不给中。。跌的全中
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3530574093705871","uuid":"3530574093705871","gmtCreate":1567480071568,"gmtModify":1665109598672,"name":"琦航爸爸","pinyin":"qhbbqihangbaba","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":27,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":4,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":664848827,"gmtCreate":1667963588870,"gmtModify":1667963589856,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06660\">$艾美疫苗(06660)$</a>流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿 <a href=\"https://laohu8.com/U/3527667588142897\">@小虎产品经理</a>","listText":"<a href=\"https://laohu8.com/S/06660\">$艾美疫苗(06660)$</a>流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿 <a href=\"https://laohu8.com/U/3527667588142897\">@小虎产品经理</a>","text":"$艾美疫苗(06660)$流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿 @小虎产品经理","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/664848827","isVote":1,"tweetType":1,"viewCount":1286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":668451670,"gmtCreate":1665107763990,"gmtModify":1665107765451,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"5.4是什么水平?","listText":"5.4是什么水平?","text":"5.4是什么水平?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/668451670","repostId":"2270292024","repostType":2,"repost":{"id":"2270292024","weMediaInfo":{"introduction":"凤凰网港股","home_visible":1,"media_name":"凤凰网港股","id":"1002821290","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"pubTimestamp":1664261039,"share":"https://www.laohu8.com/m/news/2270292024?lang=&edition=full","pubTime":"2022-09-27 14:43","market":"sh","language":"zh","title":"【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2270292024","media":"凤凰网港股","summary":"安信国际发研报指,艾美疫苗是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量排中国第二。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。","content":"<html><body><p>安信国际发研报指,<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>(06660)是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量(不含新冠疫苗)排中国第二。公司在研产品丰富,未来三年新产品将集中推出。在研疫苗中5款产品处于临床阶段,分别为针对原始毒株的mRNA新冠疫苗、减活新冠疫苗、PCV13、PPSV23及MCV4。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。</p><p>由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。因港股市场3家疫苗公司不具备可比性,例如<a href=\"https://laohu8.com/S/688185\">康希诺</a>收入以新冠疫苗为主,收入结构和艾美疫苗相差较大,瑞科生物和三叶草生物尚未有产品商业化,故该行参考可比A股上市公司同期的估值水平,即<a href=\"https://laohu8.com/S/300122\">智飞生物</a>(市销率4倍)、<a href=\"https://laohu8.com/S/300601\">康泰生物</a>(市销率9倍)和<a href=\"https://laohu8.com/S/300841\">康华生物</a>(市销率10倍),公司市销率要高于行业平均水平。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1002821290\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">凤凰网港股 </p>\n<p class=\"h-time\">2022-09-27 14:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>安信国际发研报指,<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>(06660)是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量(不含新冠疫苗)排中国第二。公司在研产品丰富,未来三年新产品将集中推出。在研疫苗中5款产品处于临床阶段,分别为针对原始毒株的mRNA新冠疫苗、减活新冠疫苗、PCV13、PPSV23及MCV4。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。</p><p>由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。因港股市场3家疫苗公司不具备可比性,例如<a href=\"https://laohu8.com/S/688185\">康希诺</a>收入以新冠疫苗为主,收入结构和艾美疫苗相差较大,瑞科生物和三叶草生物尚未有产品商业化,故该行参考可比A股上市公司同期的估值水平,即<a href=\"https://laohu8.com/S/300122\">智飞生物</a>(市销率4倍)、<a href=\"https://laohu8.com/S/300601\">康泰生物</a>(市销率9倍)和<a href=\"https://laohu8.com/S/300841\">康华生物</a>(市销率10倍),公司市销率要高于行业平均水平。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IPO":"Renaissance IPO ETF","06660":"艾美疫苗"},"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=a967c0f3706ccb4a716d7e098119feaf","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2270292024","content_text":"安信国际发研报指,艾美疫苗(06660)是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量(不含新冠疫苗)排中国第二。公司在研产品丰富,未来三年新产品将集中推出。在研疫苗中5款产品处于临床阶段,分别为针对原始毒株的mRNA新冠疫苗、减活新冠疫苗、PCV13、PPSV23及MCV4。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。因港股市场3家疫苗公司不具备可比性,例如康希诺收入以新冠疫苗为主,收入结构和艾美疫苗相差较大,瑞科生物和三叶草生物尚未有产品商业化,故该行参考可比A股上市公司同期的估值水平,即智飞生物(市销率4倍)、康泰生物(市销率9倍)和康华生物(市销率10倍),公司市销率要高于行业平均水平。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1005,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":634046851,"gmtCreate":1647308941684,"gmtModify":1647308941684,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"外资投行就是做空。。都跌到市净率一半了。。还在发做空报告","listText":"外资投行就是做空。。都跌到市净率一半了。。还在发做空报告","text":"外资投行就是做空。。都跌到市净率一半了。。还在发做空报告","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/634046851","repostId":"2219938224","repostType":2,"repost":{"id":"2219938224","pubTimestamp":1647226796,"share":"https://www.laohu8.com/m/news/2219938224?lang=&edition=full","pubTime":"2022-03-14 10:59","market":"sh","language":"zh","title":"小摩:维持新华保险“减持”评级 目标价降11.8%至15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2219938224","media":"智通财经","summary":"小摩发布研究报告称,维持新华保险(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对新华保险新业务价值的下调。报告中称,业绩重点在于新华如何分配公司资产的策略,过 ...","content":"<html><body><div>\n<p> 小摩发布研究报告称,维持<a href=\"https://laohu8.com/S/601336\">新华保险</a>(601336)(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对<a href=\"https://laohu8.com/S/01336\">新华保险</a>新业务价值的下调。</p><p> 报告中称,业绩重点在于新华如何分配公司资产的策略,过去数年,公司在净储蓄保单销售下,销售额大幅增长,该行预期随着保单到期,预期或见到更大的现金流出,加上净储蓄保单或为偿付能力资本带来压力,降低无风险资产回报亦为资产配置加添压力,故该行下调新华2021/22/23年净利润6%/5%/4%,以反映收入增长恢复减慢及投资收益下降,更调低新业务价值预测16%/20%/20%。</p><strong></strong>\n<p><strong>关注<a href=\"https://laohu8.com/S/300033\">同花顺</a>财经(ths518),获取更多机会</strong></p>\n<span></span>\n</div></body></html>","source":"tonghuashun","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>小摩:维持新华保险“减持”评级 目标价降11.8%至15港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n小摩:维持新华保险“减持”评级 目标价降11.8%至15港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-14 10:59 北京时间 <a href=http://stock.10jqka.com.cn/hks/20220314/c637437535.shtml><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>小摩发布研究报告称,维持新华保险(601336)(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对新华保险新业务价值的下调。 报告中称,业绩重点在于新华如何分配公司资产的策略,过去数年,公司在净储蓄保单销售下,销售额大幅增长,该行预期随着保单到期,预期或见到更大的现金流出,加上净储蓄保单或为偿付能力资本带来压力,降低无风险资产回报亦为资产配置加添压力,故该行下调...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20220314/c637437535.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"601336":"新华保险","01336":"新华保险"},"source_url":"http://stock.10jqka.com.cn/hks/20220314/c637437535.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","article_id":"2219938224","content_text":"小摩发布研究报告称,维持新华保险(601336)(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对新华保险新业务价值的下调。 报告中称,业绩重点在于新华如何分配公司资产的策略,过去数年,公司在净储蓄保单销售下,销售额大幅增长,该行预期随着保单到期,预期或见到更大的现金流出,加上净储蓄保单或为偿付能力资本带来压力,降低无风险资产回报亦为资产配置加添压力,故该行下调新华2021/22/23年净利润6%/5%/4%,以反映收入增长恢复减慢及投资收益下降,更调低新业务价值预测16%/20%/20%。\n关注同花顺财经(ths518),获取更多机会","news_type":1},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":308841304,"gmtCreate":1603945886408,"gmtModify":1703831341391,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06688\">$蚂蚁集团(06688)$</a>我估计蚂蚁第一天就是10左右涨幅","listText":"<a href=\"https://laohu8.com/S/06688\">$蚂蚁集团(06688)$</a>我估计蚂蚁第一天就是10左右涨幅","text":"$蚂蚁集团(06688)$我估计蚂蚁第一天就是10左右涨幅","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/308841304","isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":914276300,"gmtCreate":1581379507500,"gmtModify":1704343976614,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"亲们,这个是什么意思??","listText":"亲们,这个是什么意思??","text":"亲们,这个是什么意思??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/914276300","repostId":"2010278239","repostType":2,"repost":{"id":"2010278239","pubTimestamp":1581326139,"share":"https://www.laohu8.com/m/news/2010278239?lang=&edition=full","pubTime":"2020-02-10 17:15","market":"hk","language":"zh","title":"驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2010278239","media":"格隆汇","summary":"原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月","content":"<html><body><p>原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇</p><p>格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月9日结束。独家代表于稳定价格期间内未行使超额配股权,而超额配股权已于2020年2月9日失效。</p></body></html>","source":"sina_symbol","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-02-10 17:15 北京时间 <a href=http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-10/doc-iimxyqvz1753754.shtml><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月9日结束。独家代表于稳定价格期间内未行使超额配股权,而超额配股权已于2020年2月9日失效。</p>\n\n<a href=\"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-10/doc-iimxyqvz1753754.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825","relate_stocks":{"01745":"驴迹科技"},"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-10/doc-iimxyqvz1753754.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2010278239","content_text":"原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月9日结束。独家代表于稳定价格期间内未行使超额配股权,而超额配股权已于2020年2月9日失效。","news_type":1},"isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":916974576,"gmtCreate":1579219898995,"gmtModify":1704339309312,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"驴迹科技怎么看??中签了,昨天暗盘大跌","listText":"驴迹科技怎么看??中签了,昨天暗盘大跌","text":"驴迹科技怎么看??中签了,昨天暗盘大跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/916974576","isVote":1,"tweetType":1,"viewCount":1553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":916011582,"gmtCreate":1579156819346,"gmtModify":1704339101929,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01925\">$旷世控股(01925)$</a>这个股票太坑了。涨的不给中。。跌的全中","listText":"<a href=\"https://laohu8.com/S/01925\">$旷世控股(01925)$</a>这个股票太坑了。涨的不给中。。跌的全中","text":"$旷世控股(01925)$这个股票太坑了。涨的不给中。。跌的全中","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/916011582","isVote":1,"tweetType":1,"viewCount":1919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":919159688,"gmtCreate":1576563856644,"gmtModify":1704271990528,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"最近几个新股能打吗赤子城惠州银行台山水务","listText":"最近几个新股能打吗赤子城惠州银行台山水务","text":"最近几个新股能打吗赤子城惠州银行台山水务","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/919159688","isVote":1,"tweetType":1,"viewCount":1876,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心],虎妞已给你送上100虎币,请前往商城领取哦; 希望更多虎友看到您的帖子,可以尝试用$关联相关股票,或者发布在相关话题下面。 此外如果您想创作优质文章,这里有一份老虎社区创作指引给到您,希望能对您有帮助!","text":"终于等到了您的初发帖[比心],虎妞已给你送上100虎币,请前往商城领取哦; 希望更多虎友看到您的帖子,可以尝试用$关联相关股票,或者发布在相关话题下面。 此外如果您想创作优质文章,这里有一份老虎社区创作指引给到您,希望能对您有帮助!","html":"终于等到了您的初发帖[比心],虎妞已给你送上100虎币,请前往商城领取哦; 希望更多虎友看到您的帖子,可以尝试用$关联相关股票,或者发布在相关话题下面。 此外如果您想创作优质文章,这里有一份老虎社区创作指引给到您,希望能对您有帮助!"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":664848827,"gmtCreate":1667963588870,"gmtModify":1667963589856,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06660\">$艾美疫苗(06660)$</a>流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿 <a href=\"https://laohu8.com/U/3527667588142897\">@小虎产品经理</a>","listText":"<a href=\"https://laohu8.com/S/06660\">$艾美疫苗(06660)$</a>流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿 <a href=\"https://laohu8.com/U/3527667588142897\">@小虎产品经理</a>","text":"$艾美疫苗(06660)$流通市值怎么过百亿了??系统问题吗??别人招股说明书融资才1.7亿 @小虎产品经理","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/664848827","isVote":1,"tweetType":1,"viewCount":1286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":919159688,"gmtCreate":1576563856644,"gmtModify":1704271990528,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"最近几个新股能打吗赤子城惠州银行台山水务","listText":"最近几个新股能打吗赤子城惠州银行台山水务","text":"最近几个新股能打吗赤子城惠州银行台山水务","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/919159688","isVote":1,"tweetType":1,"viewCount":1876,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心],虎妞已给你送上100虎币,请前往商城领取哦; 希望更多虎友看到您的帖子,可以尝试用$关联相关股票,或者发布在相关话题下面。 此外如果您想创作优质文章,这里有一份老虎社区创作指引给到您,希望能对您有帮助!","text":"终于等到了您的初发帖[比心],虎妞已给你送上100虎币,请前往商城领取哦; 希望更多虎友看到您的帖子,可以尝试用$关联相关股票,或者发布在相关话题下面。 此外如果您想创作优质文章,这里有一份老虎社区创作指引给到您,希望能对您有帮助!","html":"终于等到了您的初发帖[比心],虎妞已给你送上100虎币,请前往商城领取哦; 希望更多虎友看到您的帖子,可以尝试用$关联相关股票,或者发布在相关话题下面。 此外如果您想创作优质文章,这里有一份老虎社区创作指引给到您,希望能对您有帮助!"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":308841304,"gmtCreate":1603945886408,"gmtModify":1703831341391,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06688\">$蚂蚁集团(06688)$</a>我估计蚂蚁第一天就是10左右涨幅","listText":"<a href=\"https://laohu8.com/S/06688\">$蚂蚁集团(06688)$</a>我估计蚂蚁第一天就是10左右涨幅","text":"$蚂蚁集团(06688)$我估计蚂蚁第一天就是10左右涨幅","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/308841304","isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":916974576,"gmtCreate":1579219898995,"gmtModify":1704339309312,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"驴迹科技怎么看??中签了,昨天暗盘大跌","listText":"驴迹科技怎么看??中签了,昨天暗盘大跌","text":"驴迹科技怎么看??中签了,昨天暗盘大跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/916974576","isVote":1,"tweetType":1,"viewCount":1553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":668451670,"gmtCreate":1665107763990,"gmtModify":1665107765451,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"5.4是什么水平?","listText":"5.4是什么水平?","text":"5.4是什么水平?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/668451670","repostId":"2270292024","repostType":2,"repost":{"id":"2270292024","weMediaInfo":{"introduction":"凤凰网港股","home_visible":1,"media_name":"凤凰网港股","id":"1002821290","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"pubTimestamp":1664261039,"share":"https://www.laohu8.com/m/news/2270292024?lang=&edition=full","pubTime":"2022-09-27 14:43","market":"sh","language":"zh","title":"【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2270292024","media":"凤凰网港股","summary":"安信国际发研报指,艾美疫苗是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量排中国第二。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。","content":"<html><body><p>安信国际发研报指,<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>(06660)是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量(不含新冠疫苗)排中国第二。公司在研产品丰富,未来三年新产品将集中推出。在研疫苗中5款产品处于临床阶段,分别为针对原始毒株的mRNA新冠疫苗、减活新冠疫苗、PCV13、PPSV23及MCV4。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。</p><p>由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。因港股市场3家疫苗公司不具备可比性,例如<a href=\"https://laohu8.com/S/688185\">康希诺</a>收入以新冠疫苗为主,收入结构和艾美疫苗相差较大,瑞科生物和三叶草生物尚未有产品商业化,故该行参考可比A股上市公司同期的估值水平,即<a href=\"https://laohu8.com/S/300122\">智飞生物</a>(市销率4倍)、<a href=\"https://laohu8.com/S/300601\">康泰生物</a>(市销率9倍)和<a href=\"https://laohu8.com/S/300841\">康华生物</a>(市销率10倍),公司市销率要高于行业平均水平。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【券商聚焦】安信国际予艾美疫苗(06660)IPO专用评级“5.4” 产品上市后有望带动业绩\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1002821290\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">凤凰网港股 </p>\n<p class=\"h-time\">2022-09-27 14:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>安信国际发研报指,<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>(06660)是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量(不含新冠疫苗)排中国第二。公司在研产品丰富,未来三年新产品将集中推出。在研疫苗中5款产品处于临床阶段,分别为针对原始毒株的mRNA新冠疫苗、减活新冠疫苗、PCV13、PPSV23及MCV4。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。</p><p>由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。因港股市场3家疫苗公司不具备可比性,例如<a href=\"https://laohu8.com/S/688185\">康希诺</a>收入以新冠疫苗为主,收入结构和艾美疫苗相差较大,瑞科生物和三叶草生物尚未有产品商业化,故该行参考可比A股上市公司同期的估值水平,即<a href=\"https://laohu8.com/S/300122\">智飞生物</a>(市销率4倍)、<a href=\"https://laohu8.com/S/300601\">康泰生物</a>(市销率9倍)和<a href=\"https://laohu8.com/S/300841\">康华生物</a>(市销率10倍),公司市销率要高于行业平均水平。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IPO":"Renaissance IPO ETF","06660":"艾美疫苗"},"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=a967c0f3706ccb4a716d7e098119feaf","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2270292024","content_text":"安信国际发研报指,艾美疫苗(06660)是中国大型民营疫苗企业,拥有8款针对6个疾病领域的疫苗产品和22款针对13个疾病领域的在研产品,批签发量(不含新冠疫苗)排中国第二。公司在研产品丰富,未来三年新产品将集中推出。在研疫苗中5款产品处于临床阶段,分别为针对原始毒株的mRNA新冠疫苗、减活新冠疫苗、PCV13、PPSV23及MCV4。公司预计在这5款产品中,未来1-3年至少推出4款,产品上市后有望带动业绩持续增长。由于公司2021年处于亏损状态,该行以市销率来估值,根据发行市值来测算,艾美疫苗2021年PS达12倍。因港股市场3家疫苗公司不具备可比性,例如康希诺收入以新冠疫苗为主,收入结构和艾美疫苗相差较大,瑞科生物和三叶草生物尚未有产品商业化,故该行参考可比A股上市公司同期的估值水平,即智飞生物(市销率4倍)、康泰生物(市销率9倍)和康华生物(市销率10倍),公司市销率要高于行业平均水平。虽然公司长期发展可期,综合考虑公司估值、市场情绪低迷等因素,给予IPO专用评级“5.4”。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1005,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":634046851,"gmtCreate":1647308941684,"gmtModify":1647308941684,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"外资投行就是做空。。都跌到市净率一半了。。还在发做空报告","listText":"外资投行就是做空。。都跌到市净率一半了。。还在发做空报告","text":"外资投行就是做空。。都跌到市净率一半了。。还在发做空报告","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/634046851","repostId":"2219938224","repostType":2,"repost":{"id":"2219938224","pubTimestamp":1647226796,"share":"https://www.laohu8.com/m/news/2219938224?lang=&edition=full","pubTime":"2022-03-14 10:59","market":"sh","language":"zh","title":"小摩:维持新华保险“减持”评级 目标价降11.8%至15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2219938224","media":"智通财经","summary":"小摩发布研究报告称,维持新华保险(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对新华保险新业务价值的下调。报告中称,业绩重点在于新华如何分配公司资产的策略,过 ...","content":"<html><body><div>\n<p> 小摩发布研究报告称,维持<a href=\"https://laohu8.com/S/601336\">新华保险</a>(601336)(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对<a href=\"https://laohu8.com/S/01336\">新华保险</a>新业务价值的下调。</p><p> 报告中称,业绩重点在于新华如何分配公司资产的策略,过去数年,公司在净储蓄保单销售下,销售额大幅增长,该行预期随着保单到期,预期或见到更大的现金流出,加上净储蓄保单或为偿付能力资本带来压力,降低无风险资产回报亦为资产配置加添压力,故该行下调新华2021/22/23年净利润6%/5%/4%,以反映收入增长恢复减慢及投资收益下降,更调低新业务价值预测16%/20%/20%。</p><strong></strong>\n<p><strong>关注<a href=\"https://laohu8.com/S/300033\">同花顺</a>财经(ths518),获取更多机会</strong></p>\n<span></span>\n</div></body></html>","source":"tonghuashun","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>小摩:维持新华保险“减持”评级 目标价降11.8%至15港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n小摩:维持新华保险“减持”评级 目标价降11.8%至15港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-14 10:59 北京时间 <a href=http://stock.10jqka.com.cn/hks/20220314/c637437535.shtml><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>小摩发布研究报告称,维持新华保险(601336)(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对新华保险新业务价值的下调。 报告中称,业绩重点在于新华如何分配公司资产的策略,过去数年,公司在净储蓄保单销售下,销售额大幅增长,该行预期随着保单到期,预期或见到更大的现金流出,加上净储蓄保单或为偿付能力资本带来压力,降低无风险资产回报亦为资产配置加添压力,故该行下调...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20220314/c637437535.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"601336":"新华保险","01336":"新华保险"},"source_url":"http://stock.10jqka.com.cn/hks/20220314/c637437535.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","article_id":"2219938224","content_text":"小摩发布研究报告称,维持新华保险(601336)(01336)“减持”评级,目标价由17港元下调11.8%至15港元,以反映该行对新华保险新业务价值的下调。 报告中称,业绩重点在于新华如何分配公司资产的策略,过去数年,公司在净储蓄保单销售下,销售额大幅增长,该行预期随着保单到期,预期或见到更大的现金流出,加上净储蓄保单或为偿付能力资本带来压力,降低无风险资产回报亦为资产配置加添压力,故该行下调新华2021/22/23年净利润6%/5%/4%,以反映收入增长恢复减慢及投资收益下降,更调低新业务价值预测16%/20%/20%。\n关注同花顺财经(ths518),获取更多机会","news_type":1},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":914276300,"gmtCreate":1581379507500,"gmtModify":1704343976614,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"亲们,这个是什么意思??","listText":"亲们,这个是什么意思??","text":"亲们,这个是什么意思??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/914276300","repostId":"2010278239","repostType":2,"repost":{"id":"2010278239","pubTimestamp":1581326139,"share":"https://www.laohu8.com/m/news/2010278239?lang=&edition=full","pubTime":"2020-02-10 17:15","market":"hk","language":"zh","title":"驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2010278239","media":"格隆汇","summary":"原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月","content":"<html><body><p>原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇</p><p>格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月9日结束。独家代表于稳定价格期间内未行使超额配股权,而超额配股权已于2020年2月9日失效。</p></body></html>","source":"sina_symbol","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-02-10 17:15 北京时间 <a href=http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-10/doc-iimxyqvz1753754.shtml><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月9日结束。独家代表于稳定价格期间内未行使超额配股权,而超额配股权已于2020年2月9日失效。</p>\n\n<a href=\"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-10/doc-iimxyqvz1753754.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825","relate_stocks":{"01745":"驴迹科技"},"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-10/doc-iimxyqvz1753754.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2010278239","content_text":"原标题:驴迹科技控股(01745.HK)稳定价格行动、稳定价格期间结束及超额配股权失效 来源:格隆汇格隆汇2月10日丨驴迹科技控股(01745.HK)宣布,有关全球发售的稳定价格期间已于2020年2月9日结束。独家代表于稳定价格期间内未行使超额配股权,而超额配股权已于2020年2月9日失效。","news_type":1},"isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":916011582,"gmtCreate":1579156819346,"gmtModify":1704339101929,"author":{"id":"3530574093705871","authorId":"3530574093705871","name":"琦航爸爸","avatar":"https://static.tigerbbs.com/ff3544d3e4ac2781dccc9b8a28540514","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3530574093705871","authorIdStr":"3530574093705871"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01925\">$旷世控股(01925)$</a>这个股票太坑了。涨的不给中。。跌的全中","listText":"<a href=\"https://laohu8.com/S/01925\">$旷世控股(01925)$</a>这个股票太坑了。涨的不给中。。跌的全中","text":"$旷世控股(01925)$这个股票太坑了。涨的不给中。。跌的全中","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/916011582","isVote":1,"tweetType":1,"viewCount":1919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}